| 摘要 |
<p>Transgenic mice constructed by binding the "hHB-EGF/DTR" gene to the downstream of an albumin enhancer/promoter expressed specifically in hepatic parenchymal cells and then transferring the same into mice. After confirming that the "hHB-EGF/DTR" gene has been expressed specifically in hepatic cells, diphtheria toxin is administered to the transgenic mice to examine whether the disruption of the hepatic parenchymal cells proceeds or not. Thus, the hepatic cells of the transgenic mice can be successfully disrupted selectively depending on the administration period of the diphtheria toxin.</p> |
